Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment

Cancer Immunology, Immunotherapy : CII
Katerina PilatovaLenka Zdrazilova-Dubska

Abstract

Myeloid-derived suppressor cells (MDSCs) have been shown to contribute to tumor escape from host immune surveillance and to cancer progression by production of tumor-promoting soluble factors. Granulocyte colony-stimulating factor (G-CSF) is a principle cytokine controlling granulocyte number. Recombinant human G-CSF (rhG-CSF) has become the main therapeutic agent for the treatment of neutropenia and prophylaxis of febrile neutropenia in cancer patients. However, we show here that rhG-CSF triggers accumulation of granulocytic and monocytic subsets. Consequently, we discuss the pharmacological use of granulopoiesis stimulating factors not only in the context of febrile neutropenia but also from the perspective of MDSC-dependent and MDSC-independent mechanisms of immunosuppression and cancer angiogenesis.

References

Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·B I LordT M Dexter
Mar 10, 2001·Transfusion·U PlatzbeckerK Hölig
Nov 23, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sergio RutellaGiuseppe Leone
Feb 25, 2006·Blood·Philip S RosenbergUNKNOWN Severe Chronic Neutropenia International Registry
Jun 21, 2008·Nature Reviews. Immunology·Dario A A VignaliCreg J Workman
Jul 18, 2008·Cancer Research·Farbod Shojaei, Napoleone Ferrara
Dec 6, 2008·Current Opinion in Hematology·Paolo Anderlini
Jan 10, 2009·Thrombosis and Haemostasis·Minou Adib-Conquy, Jean-Marc Cavaillon
Apr 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Farbod ShojaeiNapoleone Ferrara
Feb 23, 2010·Current Opinion in Immunology·Elisa PeranzoniVincenzo Bronte
Jun 29, 2010·Blood·Huiyuan ZhangStephanie S Watowich
Sep 30, 2010·The Journal of Experimental Medicine·Cesar A CorzoDmitry I Gabrilovich
Mar 1, 1946·Proceedings of the Society for Experimental Biology and Medicine·P B BEESON
Apr 5, 2011·Clinical Pharmacokinetics·Bing-Bing Yang, Anna Kido
May 18, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Olga M PenaRobert E W Hancock
Dec 23, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Adit Ben-Baruch
Jan 1, 2010·Journal of Blood Medicine·Chang H Kim
Feb 22, 2012·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Ariane LuyckxAn D Billiau
Jul 4, 2012·Oncoimmunology·Scott I Abrams, Jeremy D Waight
Sep 4, 2012·Journal of Oncology Practice·Marc L FishmanWilliam J M Hrushesky
Dec 18, 2012·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Viktor Umansky, Alexandra Sevko
Mar 20, 2013·Frontiers in Oncology·Yana G Najjar, James H Finke
Jun 27, 2013·Journal of Hematology & Oncology·Katerina PilatovaLenka Zdrazilova-Dubska
Sep 26, 2013·Nature Reviews. Cancer·James E Talmadge, Dmitry I Gabrilovich
Apr 3, 2014·Cancer Medicine·Alexander M AliperAlex Zhavoronkov
Apr 23, 2014·Nature Reviews. Immunology·Markus G Manz, Steffen Boettcher
Apr 9, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G H LymanJ Crawford
Jul 15, 2015·International Journal of Oncology·Michael D Allen, Louise J Jones
Jul 15, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J SmithJames O Armitage
Aug 13, 2015·Cancer Cell·Laura StraussAntonio Sica
May 30, 2016·Cellular and Molecular Life Sciences : CMLS·Christopher ShippGraham Pawelec
Jul 7, 2016·Nature Communications·Vincenzo BronteDmitry I Gabrilovich

❮ Previous
Next ❯

Citations

Apr 17, 2019·Cancers·Alessio D'AlessioBianca Maria Scicchitano
Feb 13, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ying XieSheng Liu
May 1, 2021·Journal of Clinical Medicine·Alejandro Olivares-HernándezJosé Pablo Miramontes-González

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Alexandre ChanLi Yang Hsu
Nihon rinsho. Japanese journal of clinical medicine
N Wakimoto
Nihon rinsho. Japanese journal of clinical medicine
N Wakimoto, K Motoyoshi
Nihon rinsho. Japanese journal of clinical medicine
N Wakimoto
© 2022 Meta ULC. All rights reserved